Mylan Says Generic Parkinson's Drug Approved
NEW YORK (AP) Mylan Inc. said Wednesday it started selling a generic version of Bristol-Myers Squibb Co.'s Parkinson's disease drug Sinemet.
The Food and Drug Administration approved the drug in three doses, the Pittsburgh-based company said. It launched the generic tablets after gaining approval. Sinemet is a common Parkinson's disease treatment containing two drugs, levodopa and carbidopa. Mylan said U.S. sales totaled $79 million for the 12 months ended June 30. In morning trading, Mylan shares lost 28 cents to $15.87. Shares of New York-based Bristol-Myers Squibb rose 3 cents to $22.60.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,366.15 | 1,099.92 | 2,173.14 | 33.80 |
Oil *
77.73
|
|
DOWN
86.53
|
DOWN
9.32
|
DOWN
11.89
|
UP
0.57
|
10 Yr
3.38%
SPDR Gold
118.70
|
|
-0.83%
|
-0.84%
|
-0.54%
|
+1.72%
|
Data delayed 20 minutes |
